259 related articles for article (PubMed ID: 29405306)
1. Pathogen reduction combined with rapid diagnostic tests to reduce the risk of transfusion-transmitted infections in Uganda.
Butler EK; McCullough J
Transfusion; 2018 Apr; 58(4):854-861. PubMed ID: 29405306
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
Dogbe EE; Arthur F
Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
[TBL] [Abstract][Full Text] [Related]
3. The risk of transfusion-transmitted infections in sub-Saharan Africa.
Jayaraman S; Chalabi Z; Perel P; Guerriero C; Roberts I
Transfusion; 2010 Feb; 50(2):433-42. PubMed ID: 19843290
[TBL] [Abstract][Full Text] [Related]
4. The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial.
Kasirye R; Hume HA; Bloch EM; Lubega I; Kyeyune D; Shrestha R; Ddungu H; Musana HW; Dhabangi A; Ouma J; Eroju P; de Lange T; Tartakovsky M; White JL; Kakura C; Fowler MG; Musoke P; Nolan M; Grabowski MK; Moulton LH; Stramer SL; Whitby D; Zimmerman PA; Wabwire D; Kajja I; McCullough J; Goodrich R; Quinn TC; Cortes R; Ness PM; Tobian AAR
Trials; 2022 Apr; 23(1):257. PubMed ID: 35379302
[TBL] [Abstract][Full Text] [Related]
5. Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains - experience at a resource limited blood bank.
Shittu AO; Olawumi HO; Adewuyi JO
Ghana Med J; 2014 Sep; 48(3):158-62. PubMed ID: 25709126
[TBL] [Abstract][Full Text] [Related]
6. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].
Diarra AB; Guindo A; Kouriba B; Dorie A; Diabaté DT; Diawara SI; Fané B; Touré BA; Traoré A; Gulbis B; Diallo DA
Transfus Clin Biol; 2013 Dec; 20(5-6):476-81. PubMed ID: 23916574
[TBL] [Abstract][Full Text] [Related]
7. The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors.
Rocha D; Andrade E; Godoy DT; Fontana-Maurell M; Costa E; Ribeiro M; Ferreira AGP; Brindeiro R; Tanuri A; Alvarez P
Transfusion; 2018 Apr; 58(4):862-870. PubMed ID: 29383720
[TBL] [Abstract][Full Text] [Related]
8. Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings.
Ware AD; Jacquot C; Tobian AAR; Gehrie EA; Ness PM; Bloch EM
Vox Sang; 2018 Jan; 113(1):3-12. PubMed ID: 29193128
[TBL] [Abstract][Full Text] [Related]
9. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
10. [Blood-transmitted viral infections among haemophiliacs in Tunisia].
Langar H; Triki H; Gouider E; Bahri O; Djebbi A; Sadraoui A; Hafsia A; Hafsia R
Transfus Clin Biol; 2005 Oct; 12(4):301-5. PubMed ID: 16099190
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
Mafirakureva N; Mapako T; Khoza S; Emmanuel JC; Marowa L; Mvere D; Postma MJ; van Hulst M
Transfusion; 2016 Dec; 56(12):3101-3111. PubMed ID: 27696441
[TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis B infection and transfusion-transmission risk.
Candotti D; Boizeau L; Laperche S
Transfus Clin Biol; 2017 Sep; 24(3):189-195. PubMed ID: 28673499
[TBL] [Abstract][Full Text] [Related]
13. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
[TBL] [Abstract][Full Text] [Related]
14. Screening for transfusion transmissible infections using rapid diagnostic tests in Africa: a potential hazard to blood safety?
Prugger C; Laperche S; Murphy EL; Bloch EM; Kaidarova Z; Tafflet M; Lefrère JJ; Jouven X
Vox Sang; 2016 Feb; 110(2):196-8. PubMed ID: 26646317
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
Roth WK; Weber M; Seifried E
Lancet; 1999 Jan; 353(9150):359-63. PubMed ID: 9950441
[TBL] [Abstract][Full Text] [Related]
16. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
17. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
18. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
Dwyre DM; Fernando LP; Holland PV
Vox Sang; 2011 Jan; 100(1):92-8. PubMed ID: 21175659
[TBL] [Abstract][Full Text] [Related]
20. The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review.
Pruett CR; Vermeulen M; Zacharias P; Ingram C; Tayou Tagny C; Bloch EM
Transfus Med Rev; 2015 Jan; 29(1):35-44. PubMed ID: 25447555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
